Nemaura Medical Inc (NMRD)

$0.00 0.00 (N/A)
Market Cap 4,000.00
Revenue (ttm) 80,000.00
Net Income (ttm) -14.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -17,675.00%
Debt to Equity Ratio 0.00
Volume 100
Avg Vol 10,924
Day's Range N/A - N/A
Shares Out 40.35M
Stochastic %K 0%
Beta 0.60
Analysts Strong Buy
Price Target $1.50

Company Profile

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nema...

Industry: Medical Devices
Sector: Healthcare
Phone: 646 416 8000
Address:
57 West 57th Street, Manhattan, New York, United States
NVDAMillionaire
NVDAMillionaire Mar. 28 at 7:53 AM
$NMRD Interesting tech play in CGM space. Regulatory challenges but potential game-changer with sugarBEAT. Watching closely for FDA approval and commercial traction. Might be a speculative bet for those with high risk tolerance. Keeping position small but intrigued by their innovative approach. in-depth review of recent trends: https://beyondspx.com/article/navigating-nemaura-medical-s-continuous-growth-journey-a-detailed-analysis-nmrd
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 5:10 AM
$NMRD Nemaura Medical Inc. (NMRD): Navigating the Path to Commercialization https://beyondspx.com/article/nemaura-medical-inc-nmrd-revolutionizing-diabetes-management-through-innovative-technologies
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 3:51 AM
$NMRD Nemaura Medical Inc. (NMRD): Revolutionizing Diabetes Management Through Innovative Technologies https://beyondspx.com/article/nemaura-medical-inc-nmrd-revolutionizing-diabetes-management-through-innovative-technologies
0 · Reply
Think4yourself1
Think4yourself1 Oct. 19 at 5:52 PM
$NMRD when is this fraud company being de listed? Management should be in prison. All lies and no execution.
1 · Reply
Gesundheit
Gesundheit Oct. 16 at 5:49 PM
$NMRD Ghadar-Ghadr, Arash, COO has now drained all funds from investors. I guess that was easy enough and he will go scott free?
1 · Reply
Gesundheit
Gesundheit Aug. 22 at 1:33 PM
$NMRD I see what you are doing.
0 · Reply
GoGreen21
GoGreen21 Aug. 21 at 11:01 PM
$NMRD Momentum Momentum for NMRD is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares.
0 · Reply
Gesundheit
Gesundheit Aug. 19 at 2:01 PM
$NMRD Who is doing the ripping? Don't you know that it is a crime??
0 · Reply
GoGreen21
GoGreen21 Apr. 1 at 7:50 PM
$NMRD Doubled my holdings on the dip today. Should have news any day now.
1 · Reply
WhiskyBusiness
WhiskyBusiness Mar. 26 at 7:44 PM
$NMRD Does anyone know if form 25-NSE posted on 3/21 pertains specifically to Nasdaq Cap delisting from January or is this notice of not being traded on any exchange period ?
0 · Reply
Latest News on NMRD
No data available.
NVDAMillionaire
NVDAMillionaire Mar. 28 at 7:53 AM
$NMRD Interesting tech play in CGM space. Regulatory challenges but potential game-changer with sugarBEAT. Watching closely for FDA approval and commercial traction. Might be a speculative bet for those with high risk tolerance. Keeping position small but intrigued by their innovative approach. in-depth review of recent trends: https://beyondspx.com/article/navigating-nemaura-medical-s-continuous-growth-journey-a-detailed-analysis-nmrd
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 5:10 AM
$NMRD Nemaura Medical Inc. (NMRD): Navigating the Path to Commercialization https://beyondspx.com/article/nemaura-medical-inc-nmrd-revolutionizing-diabetes-management-through-innovative-technologies
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 3:51 AM
$NMRD Nemaura Medical Inc. (NMRD): Revolutionizing Diabetes Management Through Innovative Technologies https://beyondspx.com/article/nemaura-medical-inc-nmrd-revolutionizing-diabetes-management-through-innovative-technologies
0 · Reply
Think4yourself1
Think4yourself1 Oct. 19 at 5:52 PM
$NMRD when is this fraud company being de listed? Management should be in prison. All lies and no execution.
1 · Reply
Gesundheit
Gesundheit Oct. 16 at 5:49 PM
$NMRD Ghadar-Ghadr, Arash, COO has now drained all funds from investors. I guess that was easy enough and he will go scott free?
1 · Reply
Gesundheit
Gesundheit Aug. 22 at 1:33 PM
$NMRD I see what you are doing.
0 · Reply
GoGreen21
GoGreen21 Aug. 21 at 11:01 PM
$NMRD Momentum Momentum for NMRD is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares.
0 · Reply
Gesundheit
Gesundheit Aug. 19 at 2:01 PM
$NMRD Who is doing the ripping? Don't you know that it is a crime??
0 · Reply
GoGreen21
GoGreen21 Apr. 1 at 7:50 PM
$NMRD Doubled my holdings on the dip today. Should have news any day now.
1 · Reply
WhiskyBusiness
WhiskyBusiness Mar. 26 at 7:44 PM
$NMRD Does anyone know if form 25-NSE posted on 3/21 pertains specifically to Nasdaq Cap delisting from January or is this notice of not being traded on any exchange period ?
0 · Reply
WhiskyBusiness
WhiskyBusiness Feb. 27 at 4:31 PM
$NMRD should be getting partnership news with Fiscal year March 31st approaching and authorized shares now approved . Let’s hope this milestone achieved per Faz’s previous interview comments
1 · Reply
surferbja
surferbja Feb. 23 at 12:24 AM
$NMRD The Next Level in Health Tracking https://miboko.com/sensors/ Most health trackers measure what you’re doing – like how many steps you take or how many minutes you’re active each day. Our wearable sensor measures what’s actually going on inside your body. Specifically, it tracks your metabolism, showing you how your body is responding to sugar. Because that’s actually the main influencer of everything from your appetite and weight to how well you sleep, how much energy you have, and even your mood. And longer-term it’s a big factor in chronic diseases like diabetes, heart disease, and dementia.
0 · Reply
surferbja
surferbja Feb. 23 at 12:16 AM
$NMRD Analyst Edward Woo, Ascendiant Buy 12/15/23 $3.50 In addition to the medical applications, we have developed Miboko, (www.Miboko.com), a digital healthcare program with the glucose sensor at its heart. We believe Miboko addresses a significant mass market opportunity that we believe could benefit roughly a third to half of the population by using a non-invasive glucose sensor to measure and monitor a user’s metabolic health score, which is based on glucose tolerance or insulin resistance. Those with prediabetes or obesity concerns, or even those looking to maintain better health through more careful glucose control, may benefit from such a metabolic health program. How one’s body metabolizes sugar is the main influencer of one’s appetite, weight, sleep quality, energy, and mood levels and even plays a critical factor in chronic diseases (beyond just diabetes), such as heart disease and dementia.
0 · Reply
surferbja
surferbja Feb. 23 at 12:13 AM
$NMRD Nemaura has combined our in-house diagnostic platform technology and artificial intelligence (AI) development capabilities with digital healthcare platforms through partnerships. We are positioning ourselves to become a significant player in the digital healthcare revolution through our technology offerings that will combine AI, devices, and digital platforms.
0 · Reply
surferbja
surferbja Feb. 23 at 12:12 AM
$NMRD Nemaura Medical evolved from a microsystem-based drug delivery platform that was developed in 2011. Since then, we have expanded the platform to allow the monitoring of multiple chemicals in the blood, without using needles. Replacing traditional invasive methods of diagnosis and healthcare observation procedures, our BEAT® technology will allow for remote continuous monitoring of chronic diseases and health conditions. One of the great advantages of our product, apart from eliminating the need to draw blood samples or inserting needles or sensors into the skin, is that a person can wear the device on whatever day they choose and for however long they choose. This is a unique feature of our device that has vast potential to change the way we manage chronic disease conditions.
0 · Reply
AnotherPOS
AnotherPOS Jan. 23 at 2:58 PM
$NMRD vote no to everything. Shouldn't get more money for running shareholder value to zero!
0 · Reply
MarketBeatInsiderTrades
MarketBeatInsiderTrades Jan. 10 at 12:09 AM
Nemaura Medical COO Arash Ghadar-Ghadr Buys $14,000.00 in $NMRD www.marketbeat.com/stocks/NASDAQ/NMRD/insider-trades/
1 · Reply